U.S. National Institutes of Health
U.S. National Institutes of Health


IDRankTitleRecruitmentStudy ResultsConditionsInterventionsURL
6540165401Relationship Between Dosage of Clopidogrel and Platelet Aggregation in Chinese With Different GenotypeActive, not recruitingNo Results AvailableCoronary Heart Diseasehttps://ClinicalTrials.gov/show/NCT01710436
6540265402Peer-mentored Cooking Classes for Parents of Toddlers: Do Families Cook More and Eat Healthier After the Intervention?CompletedNo Results AvailableObesityBehavioral: Peer mentoring intervention ('Cooking with Friends')https://ClinicalTrials.gov/show/NCT01710423
6540365403Transcranial Direct Current Stimulation in a Smoking Cessation TrialNot yet recruitingNo Results AvailableNicotine DependenceDevice: active transcranial Direct Current Stimulation|Device: sham transcranial Direct Current Stimulationhttps://ClinicalTrials.gov/show/NCT01710410
6540465404Rapid Initiation of Antiretroviral Therapy to Promote Early HIV/AIDS Treatment in South Africa (RapIT Study)Active, not recruitingNo Results AvailableHIVOther: Rapid ART initiationhttps://ClinicalTrials.gov/show/NCT01710397
6540565405Effect of Antenatal Corticosteroids in Late PretermNot yet recruitingNo Results AvailableLate PretermDrug: betamethasonehttps://ClinicalTrials.gov/show/NCT01710384
6540665406Quantitative 18F-AV-133 PET Imaging in Subjects With Diabetes and Healthy ControlsRecruitingNo Results AvailableType 2 DiabetesDrug: 18F-AV-133|Drug: 10% Arginine Hydrochloride-R-Gene 10https://ClinicalTrials.gov/show/NCT01710371
6540765407A Study in Moderate to Severe Rheumatoid ArthritisActive, not recruitingNo Results AvailableRheumatoid ArthritisDrug: Placebo|Drug: Adalimumab|Drug: Baricitinibhttps://ClinicalTrials.gov/show/NCT01710358
6540865408Safety and Efficacy of Sufentanil NanoTab for Management of Acute Pain Following BunionectomyCompletedHas ResultsAcute PainDrug: Sufentanil NanoTab 20 mcg|Drug: Sufentanil NanoTab 30 mcg|Drug: Placebo NanoTabhttps://ClinicalTrials.gov/show/NCT01710345
6540965409The Safety & Efficacy of Intravitreal Aflibercept Injection in Patients With Persistent Central Serous ChorioretinopathyActive, not recruitingNo Results AvailableCentral Serous ChorioretinopathyDrug: Intravitreal Aflibercept Injectionhttps://ClinicalTrials.gov/show/NCT01710332
6541065410Mechanisms of Immunosurveillance for Lung CancerRecruitingNo Results AvailableLung CancerOther: blood drawhttps://ClinicalTrials.gov/show/NCT01710319
6541165411Web and Shared Decision Making for Reserve/National Guard Women's PTSD CareEnrolling by invitationNo Results AvailablePTSDBehavioral: Phase 2https://ClinicalTrials.gov/show/NCT01710306
6541265412Automated Point-of-Care Surveillance of Outpatient Delays in Cancer Diagnosis (CREATE)WithdrawnNo Results AvailableLung Cancer|Prostate Cancer|Colorectal Cancer|Hepatocellular Carcinoma|Breast CancerBehavioral: Electronic Communication to Providershttps://ClinicalTrials.gov/show/NCT01710293
6541365413Palmitic Acid in the Sn-2 Position of Triacylglycerols and Postprandial LipemiaCompletedNo Results AvailableHealthy Men|Raised Fasting Plasma Triacylglycerol ConcentrationsDietary Supplement: High-fat meal containing native palm olein|Dietary Supplement: High-fat meal containing interesterified palm oleinhttps://ClinicalTrials.gov/show/NCT01710280
6541465414Rivaroxaban Laboratory Monitoring in Switzerland 2: Therapeutic Dose (RivaMoS 2)CompletedNo Results AvailableHealthyhttps://ClinicalTrials.gov/show/NCT01710267
6541565415Regadenoson Stress-MRI to Identify Coronary Artery Disease in Atrial Fibrillation PatientsRecruitingNo Results AvailableAtrial Fibrillation|Coronary Artery DiseaseDrug: Regadenoson MRIhttps://ClinicalTrials.gov/show/NCT01710254
6541665416Alternative Treatment Paradigm for Natalizumab TrialWithdrawnNo Results AvailableMultiple Sclerosis (MS)Drug: methylprednisolonehttps://ClinicalTrials.gov/show/NCT01710228
6541765417Comparative Effectiveness of FIT, Colonoscopy, & Usual Care Screening StrategiesEnrolling by invitationNo Results AvailableColorectal CancerOther: FIT Screening Strategy|Other: Colon Screening Strategyhttps://ClinicalTrials.gov/show/NCT01710215
6541865418Sensitivity of Short and Long Allele Carriers of the 5-HTTLPR to Environmental Threat Post Hydrocortisone AdministrationCompletedNo Results AvailableMajor Depressive Disorder|Anxiety DisordersDrug: Hydrocortisonehttps://ClinicalTrials.gov/show/NCT01710202
6541965419Cervicovaginal Immune Responses to 3 Deltoid or Thigh Intramuscular (IM) TicoVacCompletedNo Results AvailableTick-Borne EncephalitisDrug: TicoVachttps://ClinicalTrials.gov/show/NCT01710189
6542065420Localized High-Risk Soft Tissue Sarcomas Of The Extremities And Trunk Wall In Adults: An Integrating Approach Comprising Standard Vs Histotype-Tailored Neoadjuvant ChemotherapyRecruitingNo Results AvailableLocalized High-risk Soft Tissue Sarcomas of the Extremities and Trunk Wall in AdultsDrug: epirubicin 60 mg/m2/day (days 1, 2) and ifosfamide 3 g/m2/day (days 1, 2, 3)|Drug: gemcitabine 900 mg/m2 (days 1 and 8) and docetaxel 75 mg/m2 (day 8)|Drug: trabectedin 1.3 mg/m2|Drug: high-dose ifosfamide 14 g/m2, given in in 14 days|Drug: etoposide 150 mg/m2/day (days 1, 2, 3) and ifosfamide 3g/m2/day (days 1, 2, 3)|Drug: gemcitabine 1800 mg/m2 (day 1) and dacarbazine 500 mg/m2 (day 1)https://ClinicalTrials.gov/show/NCT01710176
6542165421Potentiation of Quetiapine Treatment With Lithium or Aripiprazole in Bipolar 1 Nonresponders PatientsRecruitingNo Results AvailableBipolar I DisorderDrug: Lithium|Drug: Aripiprazolehttps://ClinicalTrials.gov/show/NCT01710163
6542265422Pulmonary Vein Isolation To Reduce Future Risk Of Atrial Fibrillation In Patients Undergoing Typical FlutterWithdrawnNo Results AvailablePatients With Typical Atrial Flutter and Manifest Risk Factors With Future Development of AF.Procedure: CTI ablation alone|Procedure: CTI ablation and Pulmonary vein isolation (PVI)https://ClinicalTrials.gov/show/NCT01710150
6542365423Varenicline for Nicotine Dependence Among Those With HIV/AIDSRecruitingNo Results AvailableNicotine DependenceDrug: Varenicline|Drug: Placebo|Behavioral: Smoking Cessation Counselinghttps://ClinicalTrials.gov/show/NCT01710137
6542465424Buy 1 Get 1: Role of Grocery Coupons in Promoting Obesogenic Home Food Environments and Eating BehaviorsCompletedNo Results AvailableObesityOther: Financial incentiveshttps://ClinicalTrials.gov/show/NCT01710124
6542565425Evaluating Modes of Influenza TransmissionCompletedNo Results AvailableInfluenza, HumanDevice: Intervention Recipients Face Shieldhttps://ClinicalTrials.gov/show/NCT01710111
6542665426Treatment of Prostate Cancer With Firmagon®RecruitingNo Results AvailableProstate CancerDrug: Degarelixhttps://ClinicalTrials.gov/show/NCT01710098
6542765427Value of Diffusion Weighted Magnetic Resonance Imaging in Detection of Recurrent Disease in Surgically Treated Cervical and Endometrial Cancer PatientsRecruitingNo Results AvailableCervical Cancer|Endometrial CancerDevice: Diffusion weighted MRI (DW- MRI)- Philips Achieva 3.0T X, Netherlands, 2011https://ClinicalTrials.gov/show/NCT01710085
6542865428Aspirin Attenuates Inflammation in Human Cerebral AneurysmsCompletedNo Results AvailableThe Focus of the Study is to Monitor MRI Signal Changes and Inflammatory Biomarkers With Use of Aspirin in Patients With Unruptured Cerebral AneurysmDrug: aspirinhttps://ClinicalTrials.gov/show/NCT01710072
6542965429Using Mobile Phones to Improve Adherence to Inhaled SteroidsCompletedNo Results AvailableAsthmaBehavioral: Asthma Supervision|Behavioral: Mobile Phone|Behavioral: Inhaled Corticosteroid Mobile Phone Application|Behavioral: Beta2-adrenergic agonist Mobile Phone Applicationhttps://ClinicalTrials.gov/show/NCT01710059
6543065430Study Of The Mechanism Of Action Of CP-690,550 In The Skin Of Subjects With Moderate To Severe Chronic Plaque PsoriasisCompletedHas ResultsPlaque PsoriasisDrug: (CP-6890,550) Tofacitinib|Drug: Placebo|Drug: (CP-690,550) Tofacitinib|Drug: Placebohttps://ClinicalTrials.gov/show/NCT01710046

* Görseller ve İçerik tekif hakkına sahip olabilir